MIM
CLMT icon

MetLife Investment Management’s Calumet Specialty Products CLMT Stock Holding History

MetLife Investment Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
40,522
+1,674
+4% +$56.3K 0.01% 1330
2026
Q1 		$1.39M Sell
38,848
-358
-0.9% -$9.27K 0.01% 1245
2025
Q4 		$779K Sell
39,206
-2,508
-6% -$48.3K ﹤0.01% 1570
2025
Q3 		$761K Hold
41,714
– – ﹤0.01% 1606
2025
Q2 		$657K Buy
+41,714
New +$530K ﹤0.01% 1547

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MetLife Investment Management's CLMT Position: Q2 2026 in Review

MetLife Investment Management increased its Calumet Specialty Products (CLMT) stake by 4.3% in Q2 2026, buying an estimated $56.3K and bringing the position to 40,522 shares worth $1.46M. The position accounts for 0.01% of the portfolio, ranked #1330.

MetLife Investment Management first reported a position in CLMT in Q2 2025 and has held it in 5 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • MetLife Investment Management held 40,522 shares of Calumet Specialty Products worth $1.46M as of Q2 2026.
  • MetLife Investment Management bought 1,674 Calumet Specialty Products shares in Q2 2026, an estimated $56.3K.
  • Calumet Specialty Products made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1330 holding.
  • MetLife Investment Management first reported a position in Calumet Specialty Products in Q2 2025 and has held it in 5 quarters since.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.